Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease

Frontiers in Neuroscience
Daniel M JohnstoneJohn Mitrofanis

Abstract

Alzheimer's and Parkinson's disease are the two most common neurodegenerative disorders. They develop after a progressive death of many neurons in the brain. Although therapies are available to treat the signs and symptoms of both diseases, the progression of neuronal death remains relentless, and it has proved difficult to slow or stop. Hence, there is a need to develop neuroprotective or disease-modifying treatments that stabilize this degeneration. Red to infrared light therapy (λ = 600-1070 nm), and in particular light in the near infrared (NIr) range, is emerging as a safe and effective therapy that is capable of arresting neuronal death. Previous studies have used NIr to treat tissue stressed by hypoxia, toxic insult, genetic mutation and mitochondrial dysfunction with much success. Here we propose NIr therapy as a neuroprotective or disease-modifying treatment for Alzheimer's and Parkinson's patients.

References

Jan 1, 1989·Lasers in Surgery and Medicine·B BravermanM S Bapna
May 1, 1995·Neurobiology of Aging·H Braak, E Braak
Jan 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·J O Rinne
May 24, 2000·Progress in Neurobiology·F BlandiniE Martignoni
Feb 27, 2001·Brain : a Journal of Neurology·B HaslingerA O Ceballos-Baumann
Apr 12, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Hagai Bergman, Günther Deuschl
May 25, 2004·Stroke; a Journal of Cerebral Circulation·Paul A LapchakJustin A Zivin
Jun 15, 2004·Medical Hypotheses·Russell H Swerdlow, Shaharyar M Khan
Nov 24, 2004·The Journal of Biological Chemistry·Margaret T T Wong-RileyHarry T Whelan
Jan 26, 2005·Annals of Neurology·Rudie KortekaasN Harry Hendrikse
Feb 11, 2005·Lasers in Surgery and Medicine·Kimberly R ByrnesJuanita J Anders
May 27, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Karen M CullenJonathan Stone
May 19, 2006·Photomedicine and Laser Surgery·Kristina D DesmetHarry T Whelan
Oct 13, 2006·Neurobiology of Disease·Monica Garcia-AllozaMatthew P Frosch
Nov 4, 2006·Science·Michel Goedert, Maria Grazia Spillantini
Feb 16, 2007·Mitochondrion·Jiro FukaeNobutaka Hattori
Sep 15, 2007·Neurobiology of Learning and Memory·S MichalikovaP L Chazot
May 6, 2008·Cardiovascular Research·Derek J Hausenloy, Derek M Yellon
Jun 12, 2008·International Review of Cell and Molecular Biology·Sheng T HouRobert A Smith
Dec 17, 2008·Annals of the New York Academy of Sciences·Rajnish K Chaturvedi, M Flint Beal
Dec 17, 2008·Lancet Neurology·Alim Louis BenabidPierre Pollak
Jan 8, 2009·Annals of Neurology·C Warren OlanowAnthony H V Schapira
Feb 24, 2009·Stroke; a Journal of Cerebral Circulation·Justin A ZivinUNKNOWN NeuroThera Effectiveness and Safety Trial-2 Investigators
Jun 19, 2009·Molecular Neurodegeneration·Patricia A TrimmerUri Oron
Aug 8, 2009·Journal of Neurochemistry·Paul M CarveyAngela J Monahan
Jul 21, 2010·Proceedings of the National Academy of Sciences of the United States of America·Janet van EerselLars M Ittner
Oct 15, 2010·Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine·Carolyn B Maloney
Oct 22, 2010·Photomedicine and Laser Surgery·Thomas J McCarthyJackson Streeter

❮ Previous
Next ❯

Citations

Feb 18, 2016·Experimental Brain Research·Florian ReinhartCécile Moro
Jan 31, 2018·Experimental Brain Research·Nabil El MassriJohn Mitrofanis
Aug 24, 2018·Neural Regeneration Research·Catherine HamiltonJohn Mitrofanis
Feb 6, 2016·Journal of Experimental Neuroscience·Ann D LiebertEuahna Varigos
Sep 20, 2019·Photobiomodulation, Photomedicine, and Laser Surgery·Catherine L HamiltonJohn Mitrofanis
Oct 10, 2019·Photobiomodulation, Photomedicine, and Laser Surgery·Ann LiebertMichael R Hamblin
Sep 17, 2018·Aging·John Mitrofanis, Glen Jeffery
Jul 27, 2017·Experimental Brain Research·Cécile MoroJohn Mitrofanis
May 30, 2017·Neural Regeneration Research·John Mitrofanis
Jan 11, 2019·Dose-response : a Publication of International Hormesis Society·Jonathan StoneJanis Eells
Feb 11, 2020·Journal of Alzheimer's Disease : JAD·Xiaoran LiRong Wang
Apr 21, 2020·Frontiers in Aging Neuroscience·Aaron Song Chuan FooKah-Leong Lim
Apr 10, 2017·Journal of Neural Transmission·Marc Morissette, Thérèse Di Paolo
Dec 14, 2018·Frontiers in Physiology·Nicholas M DalesioDan E Berkowitz
Aug 10, 2019·Neural Regeneration Research·Luke C Gordon, Daniel M Johnstone
Sep 16, 2020·Biophysics Reviews·Gaurav Pandey, Vibin Ramakrishnan
Nov 20, 2020·Experimental Brain Research·Hala El KhouryLuke A Henderson
Nov 10, 2020·Journal of Alzheimer's Disease : JAD·Christopher B PopleNir Lipsman
Dec 11, 2020·Cellular and Molecular Neurobiology·Mayukha BathiniKrishna Kishore Mahato
Nov 1, 2020·International Journal of Molecular Sciences·John Buch, Billy Hammond
Feb 9, 2021·Frontiers in Neurology·Paula I MartinMargaret A Naeser
Mar 3, 2020·Biochimica Et Biophysica Acta. General Subjects·Gaurav PandeyVibin Ramakrishnan
Jun 3, 2021·International Journal of Molecular Sciences·Laura Marinela Ailioaie, Gerhard Litscher
Sep 26, 2021·Translational Neurodegeneration·Francisca MonteiroFilipe S Silva

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
transgenics

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.